Construction, non-denaturing affinity purification, and characterization of baculovirally expressed human secretory leukocyte protease inhibitor

Protein Expression and Purification

Volumn 26, Issue 1, 2002, Pages 179-186

  Gray, Laurie R ^a   Alexander, Audrey L ^a   Shugars, Diane C ^b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); UNIDENTIFIED BACULOVIRUS;

ENTEROPEPTIDASE; LEUKOCYTE ELASTASE INHIBITOR; PROTEIN; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SLPI PROTEIN, HUMAN;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARMYWORM; ARTICLE; BACULOVIRUS; CHEMISTRY; CYTOLOGY; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PROTEIN DENATURATION; PROTEIN SYNTHESIS; VIROLOGY;

ANIMALS; BACULOVIRIDAE; CHROMATOGRAPHY, AFFINITY; ENTEROPEPTIDASE; GENE EXPRESSION; HUMANS; PROTEASE INHIBITORS; PROTEIN BIOSYNTHESIS; PROTEIN DENATURATION; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SPODOPTERA;

EID: 0036421627     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00529-6     Document Type: Article

References (28)

1. J.A. Kramps, C. Franken, C.J.L.M. Meijer, Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract, J. Histochem. Cytochem. 29 (1981) 712-719.
2. F.Y. Jin, C. Nathan, D. Radzioch, A. Ding, Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide, Cell 188 (1997) 417-426.
3. J.M. Sallenave, M. Si-Ta har, G. Cox, M. Chignard, J. Gauldie, Secretory leukocyte proteinase inhibitor is a major leukocyte elastase in human neutrophils, J. Leukoc. Biol. 61 (1997) 695-702.
4. C. Franken, C.J.L.M. Meijer, J.H. Dijkman, Tissue distribution of antileukoprotease and lysozyme in humans, J. Histochem. Cytochem. 37 (1989) 493-498.
5. W.G. Rice, S.J. Weiss, Regulation of proteolysis at the neutrophil-substrate interface by secretory leukocyte protease inhibitor, Science 249 (1990) 178-181.
6. J.F. Tomee, G.H. Koeter, P.S. Heimstra, H.F. Kauffman, Secretory leukoprotease inhibitor: A native antimicrobial protein presenting a new therapeutic option? Thorax 53 (1998) 114-116.
7. P.S. Hiemstra, R.J. Maassen, J. Stolk, R. Heinzel-Wieland, G.J. Steffens, J.H. Dijkman, Antibacterial activity of antileukoprotease, Infect. Immun. 64 (1996) 4520-4524.
8. J.F.C. Tomee, P.S. Hiemstra, R. Heinzel-Wieland, H.F. Kauff-man, Antileukoprotease; an endogenous protein in the innate mucosal defense against fungi, J. Infect. Dis. 176 (1997) 740-747.
9. Y. Beppu, Y. Imamura, M. Tashiro, T. Towatari, H. Ariga, H. Kido, Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses, J. Biochem. 121 (1997) 309-316.
10. T.B. McNeely, M. Dealy, D.J. Dripps, J.M. Orenstein, S.P. Eisenberg, S.M. Wahl, Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro, J. Clin. Invest. 96 (1995) 456-464.
11. T.B. McNeely, D.C. Shugars, C. Tucker, M. Rosendahl, S.P. Eisenberg, S.M. Wahl, Secretory leukocyte protease inhibitor binds to monocytes and inhibits HIV-1 infectivity prior to viral reverse transcription, Blood 90 (1997) 1141-1149.
12. D.C. Shugars, D.L. Saul, J.B. Weinberg, Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1, Oral Dis. 3 (Suppl. 1) (1997) S70-S72.
13. S.M. Wahl, T.B. McNeely, E.N. Janoff, D. Shugars, P. Worley, C. Tucker, J.M. Orenstein, Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV, Oral Dis. 3 (Suppl. 1) (1997) S64-S69.
14. K. Pillay, A. Coutsoudis, A.K. Agadzi-Nazvi, L. Kuhn, H.M. Coovadia, E.N. Jano1, Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission, J. Infect. Dis. 183 (2001) 653-656.
15. G.S. Ashcroft, K. Lei, W. Jin, G. Longenecker, A.B. Kulkarni, T. Greenwell-Wild, H. Hale-Donze, G. McGrady, X.Y. Song, S.M. Wahl, Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing, Nat. Med. 6 (2000) 1147-1153.
16. M.G. Grütter, G. Fendrich, R. Huber, W. Bode, The 2.5 Å X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analyzed in its complex with bovine α-chymotrypsin, EMBO J. 7 (1988) 345-351.
17. R.C. Thompson, K. Ohlsson, Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase, Proc. Natl. Acad. Sci. USA 83 (1986) 6692-6696.
18. S.P. Eisenberg, K.K. Hale, P. Heimdal, R.C. Thompson, Location of the protease-inhibitory region of secretory leukocyte protease inhibitor, J. Biol. Chem. 265 (1990) 7976-7981.
19. J. Schalkwijk, O. Wiedow, S. Hirose, The trappin gene family: Proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core, Biochem. J. 340 (1999) 569-577.
20. Q.L. Ying, M. Kemme, S.R. Simon, Functions of the N-terminal domain of secretory leukoprotease inhibitor, Biochemistry 33 (1994) 5445-5450.
21. E.G. Lucey, P.J. Stone, D.E. Ciccolella, R. Breuer, T.G. Chris-tensen, R.C. Thompson, G.L. Snider, Recombinant human secretory leukocyte-protease inhibitor: In vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster, J. Lab. Clin. Med. 115 (1990) 224-232.
22. R.J. Seely, M.D. Young, Large-scale refolding of secretory leukocyte protease inhibitor, in: G. Georgiou, E. DeBernardez-Clark (Eds.), Protein Refolding, ACS Symposium Series, 470, American Chemical Society, Washington, DC, 1991, pp. 206-216.
23. S.W. Harcum, B.E. Dale, R.J. Seely, Renaturation of recombinant secretory leukocyte protease inhibitor: Aspects of disulfide bond formation kinetics, Biotechnol. Lett. 15 (1993) 943-948.
24. K.W. Miller, R.J. Evans, S.P. Eisenberg, R.C. Thompson, Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli, J. Bacteriol. 171 (1989) 2166-2172.
25. U.K. Laemmli, Cleavage of structural protein during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
26. E.G. DelMar, C. Largman, J.W. Brodrick, M.C. Geokas, A sensitive new substrate for chymotrypsin, Anal. Biochem. 99 (1979) 316-320.
27. W.C. Groutas, M.J. Brubaker, R. Venkataraman, J.B. Epp, M.A. Stanga, J.J. McClenahan, Inhibitors of human neutrophil cathepsin G: structural and biochemical studies, Arch. Biochem. Biophys. 294 (1992) 144-146.
28. W.B. Schill, O. Wallner, H. Schiessler, H. Fritz, Immunofluorescence localization of the acid-stable proteinase inhibitor (antileukoprotease) of human cervical mucus, Experientia 34 (1978) 509-510.